Request Appointment
428 E 72nd StOfc 400New York, NY 10021
Fax+1 212-746-8296
Overview of Dr. Sarva
Dr. Harini Sarva is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and Long Island Jewish Medical Center. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 13 years. She is one of 475 doctors at New York-Presbyterian Hospital and one of 111 doctors at Long Island Jewish Medical Center who specialize in Neurology. She has more than 60 publications and over 500 citings.
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Neurology, 2008 - 2012
State University of New York Downstate Medical Center College of MedicineClass of 2004
Certifications & Licensure
NY State Medical License 2011 - 2026
NJ State Medical License 2020 - 2023
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants Start of enrollment: 2022 Oct 05
Roles: Principal Investigator
Publications & Presentations
PubMed
- Liver fibrosis associated with more severe motor deficits in early Parkinson's disease.Aryeh Zolin, Hwai Ooi, Manqi Zhou, Chang Su, Fei Wang
Clinical Neurology and Neurosurgery. 2025-05-01 - Adult-Onset Myoclonus in a Large Urban Inpatient Setting: A Retrospective Cohort Study.Karin Oh, Moath Hamed, Donna Zarandi, Moyosore Oluleye, Anas Zaher
Tremor and Other Hyperkinetic Movements. 2025-01-01 - 5 citationsSafety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor: An Open-Label Clinical Trial.Michael G Kaplitt, Vibhor Krishna, Howard M Eisenberg, W Jeffrey Elias, Pejman Ghanouni
JAMA Neurology. 2024-09-01
Press Mentions
Stem Cell Therapy Shows Promise for Treating Advanced Parkinson's DiseaseApril 15th, 2025- Mitsubishi Tanabe Pharma America to Highlight Latest Advances in Neurodegenerative Research at the American Academy of Neurology 2025 Annual MeetingApril 3rd, 2025
- BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson’s Disease Clinical TrialMarch 14th, 2023
- Join now to see all
Grant Support
- Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)COLUMBIA UNIVERSITY HEALTH SCIENCES2018–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
